← Leaderboards
Yong-Yu Liu
Louisiana State Univ A&M Col Baton Rouge
$912,319
Attributed
$912,319
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $413.4K · FY2007–13$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$912,319 · 6
By mechanism
P20$498,925 · 5
R15$413,394 · 1
Top collaborators
No co-investigators on record.
Most similar at Louisiana State Univ A&M Col Baton Rouge
Same institution · by research overlap
- Tracey A Simmons-Willis$13,572
Others in their field
Top investigators on “Funding”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,479,940,681
- Leonard Freedman · Leidos Biomedical Research, Inc.$968,195,877
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$358,470,093
Research focus
FundingUnited States National Institutes Of HealthChemotherapyGenesCeramidesCeramide GlucosyltransferaseResourcesGrantSourceIn VivoNeoplasm MetastasisDrug ResistanceMixed-Backbone OligonucleotideDoxorubicinCellsInstitutionCancer TherapyComputer Retrieval Of Information On Scientific Projects DatabaseResearch PersonnelGlycosylationTumorMcf7 CellMalignant NeoplasmsMalignant Breast Neoplasm
Grant awards (6)
Ceramide glycosylation determines the stemness of cancer stem cells$413,394
R15 · FY2013 · CA · contact PI
EPIGENETIC EFFECTS OF CERAMIDE GLYCOSYLATION AND DRUG-RESISTANT CANCER STEM CELL$164,824
P20 · FY2011 · RR · contact PI
GLUCOSYLCERAMIDE SYNTHASE IN A NOVEL TARGET FOR CANCER TREATMENT$109,837
P20 · FY2010 · RR · contact PI
GLUCOSYLCERAMIDE SYNTHASE IN A NOVEL TARGET FOR CANCER TREATMENT$77,552
P20 · FY2009 · RR · contact PI
GLUCOSYLCERAMIDE SYNTHASE IN A NOVEL TARGET FOR CANCER TREATMENT$93,087
P20 · FY2008 · RR · contact PI
GLUCOSYLCERAMIDE SYNTHASE IN A NOVEL TARGET FOR CANCER TREATMENT$53,625
P20 · FY2007 · RR · contact PI